Summary of 2025 CSI Annual Meeting (17th CSI Congress of Immunology)
Source：CSI
2025-11-19
From November 6-9, 2025, the 2025 CSI Annual Meeting (CSI2025) was successfully held in Chongqing. The congress achieved fruitful results, summarized in the following seven aspects:
1. Academic Influence Continues to Grow
This year’s conference set new records, receiving 1,929 abstracts, an increase of 572 compared with last year (up 42%). A total of 3,115 registered participants attended, and together with invited guests, exhibitors, and volunteers, the onsite attendance reached 4,285, fully demonstrating the vigorous development of immunology in China and the strong cohesion of the conference brand.
2. Keynote Lectures Leading the Frontiers
International keynote speakers included: Prof. Frederick Alt, Harvard Medical School; Prof. Tak Mak, University of Toronto; Prof. Anne O’Garra, Francis Crick Institute; Prof. Bernard Malissen, Marseille Immunology Center; Prof. Rudolf Valenta, Medical University of Vienna; Prof. Geoffrey Smith, Shanghai Institute of Immunology and Infection, Chinese Academy of Sciences.
Domestic keynote lectures included 24 presentations:
• 6 Academician lectures (led by Prof. Xuetao Cao, Prof. Zhigang Tian, Prof. Yuzhang Wu, etc.)
• 10 Frontier progress lectures (led by Prof. Bo Huang, President of the Chinese Society for Immunology)
• 8 Young scholar lectures (led by Prof. Cai Zhijian, Zhejiang University)
In total, 30 plenary lectures covered cutting-edge topics such as: advances in immune checkpoint blockade therapies, mechanisms of tuberculosis immunity, CD28-independent tumor-specific T cell responses, allergen molecules and allergy vaccines, innate immunity to poxviruses, novel targets and mechanisms in immunotherapy, logic-gated technologies for intelligent immunotherapy, decoding and rebuilding human immunity, ADP-heptose/ALPK1 innate immune pathways, tumor vascular microenvironment and immune heterogeneity, cellular functional units in tumor microenvironment, translational immunobiology, and ROS regulation frameworks. Numerous outstanding young scholars emerged, reflecting the promising growth of China’s next generation of immunologists.
3. Parallel Sessions and Poster Exchanges
From nearly 2,000 submissions, the Academic Committee selected 378 oral presentations across 22 parallel sessions, along with 403 poster presentations. A new “Respiratory Immunology” track was introduced for the first time, receiving enthusiastic responses. Hot topics such as “Tumor Immune Recognition and Evasion,” “Immunometabolism,” and “Innate Immune Recognition and Inflammation” drew packed audiences and lively discussions.
4. Pre-congress Forums and Activities
Eight pre-conference forums were held: Hong Kong–Macau Forum, Immunomechanics Forum, Immunosenescence Forum, Tumor Immunology Innovation Forum, Immunometabolism Forum, Cardiovascular Immunology Forum, Immune Cell Therapy for Major Diseases Forum, and CSI–JSI–KAI Youth Forum, all receiving strong participation.
At the opening ceremony, a special memorial session honored Prof. David Baltimore, an internationally renowned immunologist and friend of China, with Prof. Frederick Alt delivering a tribute. Additional events included the Medical Immunology Textbook and Curriculum Development Seminar and the “Meet the Editors” session, featuring senior editors from Nature Cell Biology and Journal of Experimental Medicine, fostering talent development and encouraging scholarly publication.
5. CSI Academic Awards
The 13th Academic Awards of the Chinese Society for Immunology were presented at the opening ceremony:
• Lifetime Achievement Award: Prof. Zhigang Tian
• Outstanding Scholar Award: Prof. Bing Sun and Prof. Li Wu
• Young Scholar Award: 10 young immunologists
The awardees delivered inspiring remarks, expressing hopes for the continued advancement of immunology in China.
6. Strong Industry Support
A total of 82 enterprises participated in exhibitions and satellite meetings, including:
• Strategic Partner: BD Biosciences
• Gold Sponsors: Dakewe Biotech Co., Ltd. & BioLegend (Beijing) Ltd.
• Silver Sponsor: ABclonal Technology Co., Ltd.
• Bronze Sponsors: Cytek Biosciences, Beijing Challen Biotechnology Co., Ltd., Thermo Fisher Scientific (China) Co., Ltd., STEMCELL Technologies, Proteintech, Beckman Coulter Life Sciences, Elabscience Biotechnology Co., Ltd., among others
As a long-term partner, Dingxiangyuan (DXY) provided live coverage and interviews, further amplifying the conference’s academic and social impact.
7. Efficient Organization and Support
Under the leadership of the 9th Council and the 2nd Supervisory Board, the Academic and Organizing Committees devoted great effort to planning, coordination, and oversight. The volunteer team organized by the Chongqing Immunology Society and Chongqing Medical University provided excellent onsite services and logistical support, ensuring the smooth operation of the conference.
The conference concluded in a rich academic atmosphere. At the closing ceremony, Prof. Huang Bo, President of the Society, led participants in reviewing highlights of the meeting and warmly invited all representatives to reconvene in Changsha in November 2026 for the next annual gathering.
1. Academic Influence Continues to Grow
This year’s conference set new records, receiving 1,929 abstracts, an increase of 572 compared with last year (up 42%). A total of 3,115 registered participants attended, and together with invited guests, exhibitors, and volunteers, the onsite attendance reached 4,285, fully demonstrating the vigorous development of immunology in China and the strong cohesion of the conference brand.
2. Keynote Lectures Leading the Frontiers
International keynote speakers included: Prof. Frederick Alt, Harvard Medical School; Prof. Tak Mak, University of Toronto; Prof. Anne O’Garra, Francis Crick Institute; Prof. Bernard Malissen, Marseille Immunology Center; Prof. Rudolf Valenta, Medical University of Vienna; Prof. Geoffrey Smith, Shanghai Institute of Immunology and Infection, Chinese Academy of Sciences.
Domestic keynote lectures included 24 presentations:
• 6 Academician lectures (led by Prof. Xuetao Cao, Prof. Zhigang Tian, Prof. Yuzhang Wu, etc.)
• 10 Frontier progress lectures (led by Prof. Bo Huang, President of the Chinese Society for Immunology)
• 8 Young scholar lectures (led by Prof. Cai Zhijian, Zhejiang University)
In total, 30 plenary lectures covered cutting-edge topics such as: advances in immune checkpoint blockade therapies, mechanisms of tuberculosis immunity, CD28-independent tumor-specific T cell responses, allergen molecules and allergy vaccines, innate immunity to poxviruses, novel targets and mechanisms in immunotherapy, logic-gated technologies for intelligent immunotherapy, decoding and rebuilding human immunity, ADP-heptose/ALPK1 innate immune pathways, tumor vascular microenvironment and immune heterogeneity, cellular functional units in tumor microenvironment, translational immunobiology, and ROS regulation frameworks. Numerous outstanding young scholars emerged, reflecting the promising growth of China’s next generation of immunologists.
3. Parallel Sessions and Poster Exchanges
From nearly 2,000 submissions, the Academic Committee selected 378 oral presentations across 22 parallel sessions, along with 403 poster presentations. A new “Respiratory Immunology” track was introduced for the first time, receiving enthusiastic responses. Hot topics such as “Tumor Immune Recognition and Evasion,” “Immunometabolism,” and “Innate Immune Recognition and Inflammation” drew packed audiences and lively discussions.
4. Pre-congress Forums and Activities
Eight pre-conference forums were held: Hong Kong–Macau Forum, Immunomechanics Forum, Immunosenescence Forum, Tumor Immunology Innovation Forum, Immunometabolism Forum, Cardiovascular Immunology Forum, Immune Cell Therapy for Major Diseases Forum, and CSI–JSI–KAI Youth Forum, all receiving strong participation.
At the opening ceremony, a special memorial session honored Prof. David Baltimore, an internationally renowned immunologist and friend of China, with Prof. Frederick Alt delivering a tribute. Additional events included the Medical Immunology Textbook and Curriculum Development Seminar and the “Meet the Editors” session, featuring senior editors from Nature Cell Biology and Journal of Experimental Medicine, fostering talent development and encouraging scholarly publication.
5. CSI Academic Awards
The 13th Academic Awards of the Chinese Society for Immunology were presented at the opening ceremony:
• Lifetime Achievement Award: Prof. Zhigang Tian
• Outstanding Scholar Award: Prof. Bing Sun and Prof. Li Wu
• Young Scholar Award: 10 young immunologists
The awardees delivered inspiring remarks, expressing hopes for the continued advancement of immunology in China.
6. Strong Industry Support
A total of 82 enterprises participated in exhibitions and satellite meetings, including:
• Strategic Partner: BD Biosciences
• Gold Sponsors: Dakewe Biotech Co., Ltd. & BioLegend (Beijing) Ltd.
• Silver Sponsor: ABclonal Technology Co., Ltd.
• Bronze Sponsors: Cytek Biosciences, Beijing Challen Biotechnology Co., Ltd., Thermo Fisher Scientific (China) Co., Ltd., STEMCELL Technologies, Proteintech, Beckman Coulter Life Sciences, Elabscience Biotechnology Co., Ltd., among others
As a long-term partner, Dingxiangyuan (DXY) provided live coverage and interviews, further amplifying the conference’s academic and social impact.
7. Efficient Organization and Support
Under the leadership of the 9th Council and the 2nd Supervisory Board, the Academic and Organizing Committees devoted great effort to planning, coordination, and oversight. The volunteer team organized by the Chongqing Immunology Society and Chongqing Medical University provided excellent onsite services and logistical support, ensuring the smooth operation of the conference.
